Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64,326,281
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
37,354,429
-
Shares change
-
+18,991,469
-
Total reported value, excl. options
-
$289,749,375
-
Value change
-
+$137,823,510
-
Put/Call ratio
-
140%
-
Number of buys
-
51
-
Number of sells
-
-18
-
Price
-
$7.76
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q1 2023
82 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q1 2023.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,354,429 shares
of 64,326,281 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include FMR LLC (5,796,259 shares), Sofinnova Investments, Inc. (3,467,156 shares), Kynam Capital Management, LP (3,372,428 shares), Carlyle Group Inc. (2,960,231 shares), COMMODORE CAPITAL LP (2,824,029 shares), MILLENNIUM MANAGEMENT LLC (1,887,351 shares), Eversept Partners, LP (1,788,529 shares), Woodline Partners LP (1,752,718 shares), BlackRock Inc. (1,410,270 shares), and VANGUARD GROUP INC (1,394,851 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.